# ProKidney Announces Two Abstracts Selected for Presentation at the American Society of Nephrology’s Kidney Week 2025
Canonical URL: https://biopharmsignal.com/news/PROK/prokidney-announces-two-abstracts-selected-for-presentation-at-the-american-society-of-nephrology-s-kidney-week-2025
Ticker: PROK
Company: ProKidney
Source: ProKidney
Published: 2025-10-20 11:30 EST
Original Source URL: https://investors.prokidney.com
## Summary

WINSTON-SALEM, N.C., Oct. 20, 2025 (GLOBE NEWSWIRE) -- ProKidney Corp. (Nasdaq: PROK)  (“ProKidney” or the “Company"), a leading late clinical-stage cellular therapeutics company focused on chronic kidney disease (CKD), today announced that the Company will present two posters, including a

## Article Body
WINSTON-SALEM, N.C., Oct. 20, 2025 (GLOBE NEWSWIRE) -- ProKidney Corp. (Nasdaq: PROK)  (“ProKidney” or the “Company"), a leading late clinical-stage cellular therapeutics company focused on chronic kidney disease (CKD), today announced that the Company will present two posters, including a
## Recent Company News
- 2026-06-02 12:00 EST — [ProKidney Appoints Kenneth Locke as Chief Technical Officer](https://biopharmsignal.com/news/PROK/prokidney-appoints-kenneth-locke-as-chief-technical-officer) — Source: ProKidney
- 2026-05-15 15:45 EST — [ProKidney Reports First Quarter 2026 Financial Results and Business Highlights](https://biopharmsignal.com/news/PROK/prokidney-reports-first-quarter-2026-financial-results-and-business-highlights) — Source: ProKidney
- 2026-03-25 20:01 EST — [ProKidney Expands Senior Leadership Team with Appointment of Greg Madison as Chief Commercial Officer](https://biopharmsignal.com/news/PROK/prokidney-expands-senior-leadership-team-with-appointment-of-greg-madison-as-chief-commercial-officer) — Source: ProKidney
- 2026-03-18 20:00 EST — [ProKidney Reports Full Year 2025 Financial Results and Business Highlights](https://biopharmsignal.com/news/PROK/prokidney-reports-full-year-2025-financial-results-and-business-highlights) — Source: ProKidney
- 2026-01-06 12:30 EST — [ProKidney to Present at the 44th Annual J.P. Morgan Healthcare Conference](https://biopharmsignal.com/news/PROK/prokidney-to-present-at-the-44th-annual-j-p-morgan-healthcare-conference) — Source: ProKidney
## Related News
- 2026-07-29 13:00 EST — ENLV — [Enlivex Management to Host Webinar to Discuss Capital Strategy, Rain Protocol Treasury Strategy, and Recent Clinical Milestones](https://biopharmsignal.com/news/ENLV/enlivex-management-to-host-webinar-to-discuss-capital-strategy-rain-protocol-tre-5921a627)
- 2026-07-29 12:30 EST — PRGO — [Perrigo to Present at the Canaccord 46th Annual Growth Conference](https://biopharmsignal.com/news/PRGO/perrigo-to-present-at-the-canaccord-46th-annual-growth-conference-40431922)
- 2026-07-29 12:30 EST — LIXT — [NOMAD Announces Operational Deployment of Two Mobile Battery Systems by DSO Electric Cooperative](https://biopharmsignal.com/news/LIXT/nomad-announces-operational-deployment-of-two-mobile-battery-systems-by-dso-elec-7fc12a2c)
- 2026-07-29 12:30 EST — RNXT — [RenovoRx to Host Second Quarter 2026 Financial Results and Business Highlights Conference Call on August 12th at 4:30 p.m. ET](https://biopharmsignal.com/news/RNXT/renovorx-to-host-second-quarter-2026-financial-results-and-business-highlights-c-8bed10ec)
- 2026-07-29 12:25 EST — ICCM — [IceCure: SIO Petitions NCCN to Include Cryoablation in Breast Cancer Treatment Guidelines, Citing IceCure's FDA Clearance  of ProSense®](https://biopharmsignal.com/news/ICCM/icecure-sio-petitions-nccn-to-include-cryoablation-in-breast-cancer-treatment-gu-bec46cd3)